The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
Sulphadoxine/pyrimethamine (SP) is often administered with quinine in the treatment of severe falciparum malaria to shorten the course of quinine. The efficacy of SP alone in the treatment of non-severe malaria has been declining rapidly in East Africa, raising concerns of the usefulness of a shorte...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2005
|
| _version_ | 1797052596234485760 |
|---|---|
| author | Ogutu, B Nzila, A Ochong, E Mithwani, S Wamola, B Olola, C Lowe, B Kokwaro, G Marsh, K Newton, C |
| author_facet | Ogutu, B Nzila, A Ochong, E Mithwani, S Wamola, B Olola, C Lowe, B Kokwaro, G Marsh, K Newton, C |
| author_sort | Ogutu, B |
| collection | OXFORD |
| description | Sulphadoxine/pyrimethamine (SP) is often administered with quinine in the treatment of severe falciparum malaria to shorten the course of quinine. The efficacy of SP alone in the treatment of non-severe malaria has been declining rapidly in East Africa, raising concerns of the usefulness of a shortened course of quinine followed SP. We audited the efficacy of quinine/SP in the treatment of severe malaria in Kenyan children. Children with severe falciparum malaria were treated with parenteral quinine followed by a single oral dose of SP. A clinical evaluation was performed 3 weeks later in which a blood sample was obtained for full haemogram, blood slide and analysis of the parasite dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) codons, mutations of which are associated with resistance to SP. A total of 452 children were enrolled, of whom 374 completed the study. Fifty-two (13.9%) children were parasitaemic by 3 weeks of whom 17 (4.5%) had fever as well. The treatment failure group had a significantly higher parasitaemia (129 061 vs. 43 339; P<0.001) and haemoglobin on admission, but only admission parasitaemia independently predicted treatment failure. Those with treatment failure had a significantly lower rise in haemoglobin at 3 weeks compared with treatment successes (9.0 vs. 10.0 g/dl). Of the 76 parasite isolates collected before treatment, 40 (53%) were triple mutant DHFR-double DHPS (Tp-Db), the genotype most associated with SP resistance. Three weeks after SP treatment, the proportion of Tp-Db increased to 72% (31/43). The high treatment failure rate and proportion of parasites with Tp-Db negate the use of SP to shorten the course of quinine treatment in East Africa. |
| first_indexed | 2024-03-06T18:33:43Z |
| format | Journal article |
| id | oxford-uuid:0a8637b0-afa2-4200-90a2-be93edf09b35 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:33:43Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:0a8637b0-afa2-4200-90a2-be93edf09b352022-03-26T09:24:17ZThe role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0a8637b0-afa2-4200-90a2-be93edf09b35EnglishSymplectic Elements at Oxford2005Ogutu, BNzila, AOchong, EMithwani, SWamola, BOlola, CLowe, BKokwaro, GMarsh, KNewton, CSulphadoxine/pyrimethamine (SP) is often administered with quinine in the treatment of severe falciparum malaria to shorten the course of quinine. The efficacy of SP alone in the treatment of non-severe malaria has been declining rapidly in East Africa, raising concerns of the usefulness of a shortened course of quinine followed SP. We audited the efficacy of quinine/SP in the treatment of severe malaria in Kenyan children. Children with severe falciparum malaria were treated with parenteral quinine followed by a single oral dose of SP. A clinical evaluation was performed 3 weeks later in which a blood sample was obtained for full haemogram, blood slide and analysis of the parasite dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) codons, mutations of which are associated with resistance to SP. A total of 452 children were enrolled, of whom 374 completed the study. Fifty-two (13.9%) children were parasitaemic by 3 weeks of whom 17 (4.5%) had fever as well. The treatment failure group had a significantly higher parasitaemia (129 061 vs. 43 339; P<0.001) and haemoglobin on admission, but only admission parasitaemia independently predicted treatment failure. Those with treatment failure had a significantly lower rise in haemoglobin at 3 weeks compared with treatment successes (9.0 vs. 10.0 g/dl). Of the 76 parasite isolates collected before treatment, 40 (53%) were triple mutant DHFR-double DHPS (Tp-Db), the genotype most associated with SP resistance. Three weeks after SP treatment, the proportion of Tp-Db increased to 72% (31/43). The high treatment failure rate and proportion of parasites with Tp-Db negate the use of SP to shorten the course of quinine treatment in East Africa. |
| spellingShingle | Ogutu, B Nzila, A Ochong, E Mithwani, S Wamola, B Olola, C Lowe, B Kokwaro, G Marsh, K Newton, C The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. |
| title | The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. |
| title_full | The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. |
| title_fullStr | The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. |
| title_full_unstemmed | The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. |
| title_short | The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children. |
| title_sort | role of sequential administration of sulphadoxine pyrimethamine following quinine in the treatment of severe falciparum malaria in children |
| work_keys_str_mv | AT ogutub theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT nzilaa theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT ochonge theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT mithwanis theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT wamolab theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT ololac theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT loweb theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT kokwarog theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT marshk theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT newtonc theroleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT ogutub roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT nzilaa roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT ochonge roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT mithwanis roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT wamolab roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT ololac roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT loweb roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT kokwarog roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT marshk roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren AT newtonc roleofsequentialadministrationofsulphadoxinepyrimethaminefollowingquinineinthetreatmentofseverefalciparummalariainchildren |